New Medicines in Development Report on HIV/AIDS

America’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention, according to the latest Medicines in Development report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

A second report, a PhRMA-sponsored white paper by Boston Healthcare Associates, Inc. (BHA), ―The Value of Innovation in HIV/AIDS Therapy, highlights the progress in HIV/AIDS treatment and its impact on patients afflicted with the disease. Both reports were released in conjunction with PhRMA’s 2014 Research & Hope Awards, honoring researchers and patient advocates for their role in improving HIV/AIDS research and care.